| Disease Subtype(s) |
HCT Disease Inserts |
Cellular Therapy Disease Inserts |
Diseases of Immune Dysregulation, Familial Hemophagocytic Lymphohistiocytosis (FHL)
- Familial Hemophagocytic Lymphohistiocytosis, Perforin deficiency (FHL2) (2511)
- Familial Hemophagocytic Lymphohistiocytosis, UNC13D (FHL3) (2512)
- Familial Hemophagocytic Lymphohistiocytosis, STX11 (FHL4) (2513)
- Familial Hemophagocytic Lymphohistiocytosis, STXBP2 (FHL5) (2514)
- Familial Hemophagocytic Lymphohistiocytosis, no mutation identified (2515)
- Familial Hemophagocytic Lymphohistiocytosis, other mutations (2516)
|
Form 2039 & 2139 |
No disease inserts required |
- Langerhans cell histiocytosis (histiocytosis-X) (572)
|
Form 2040 & 2140 |
- Hemophagocytosis (reactive or viral associated) (573)
- Malignant histiocytosis (574)
- Other histiocytic disorder (579)
- Histiocytic disorder, not otherwise specified (570)
|
No disease inserts required |
Diseases of Immune Dysregulation, Hemophagocytic Lymphohistiocytosis
- Chediak-Higashi syndrome (456)
- Griscelli syndrome type 2 (465)
- Hermansky-Pudlak syndrome type 2 (466)
- Other pigmentary dilution disorder (469)
|
Forms 2056 & 2156 |
Diseases of Immune Dysregulation, EBV susceptibility
- SAP deficiency (XIAP-1) (458)
- XIAP-2 deficiency (2420)
- ITK deficiency (2421)
|
Forms 2034 & 2134 |
Last modified:
Feb 17, 2026
